- Home
- MSB vs LFCR Comparison
MSB vs LFCR Comparison
Compare MSB & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSB | LFCR |
|---|---|---|
| Founded | 1961 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 320.9M | 296.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MSB | LFCR |
|---|---|---|
| Price | $40.43 | $7.91 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 51.7K | ★ 176.0K |
| Earning Date | 04-24-2026 | 01-02-2026 |
| Dividend Yield | ★ 17.01% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.31 | N/A |
| Revenue | $20,785,076.00 | ★ $128,867,000.00 |
| Revenue This Year | N/A | $2.80 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | $31.06 | ★ N/A |
| Revenue Growth | N/A | ★ 0.47 |
| 52 Week Low | $22.55 | $4.76 |
| 52 Week High | $41.91 | $8.85 |
Technical Indicators
Market Signals| Indicator | MSB | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 65.71 | 50.12 |
| Support Level | $36.50 | $7.66 |
| Resistance Level | $41.91 | $8.36 |
| Average True Range (ATR) | 2.12 | 0.43 |
| MACD | 0.45 | -0.06 |
| Stochastic Oscillator | 82.90 | 35.03 |
Price Performance
Historical ComparisonAbout MSB Mesabi Trust
Mesabi Trust operates as a royalty trust in the United States. The company is involved in the conservation and protection of its assets. The company's principally wholly-owned segment is the iron ore mining segment, which generates income from the Peter Mitchell Mine, an iron mine located near Babbitt, Minnesota, at the eastern end of the Mesabi Iron Range.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.